These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15973860)

  • 1. Metabolic syndrome.
    Love A; Oldford D
    Can J Cardiovasc Nurs; 2005; 15(2):6-8; quiz 9. PubMed ID: 15973860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to best define the metabolic syndrome.
    Magliano DJ; Shaw JE; Zimmet PZ
    Ann Med; 2006; 38(1):34-41. PubMed ID: 16448987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex web of risks for metabolic syndrome: race/ethnicity, economics, and gender.
    Salsberry PJ; Corwin E; Reagan PB
    Am J Prev Med; 2007 Aug; 33(2):114-20. PubMed ID: 17673098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular morbidity and mortality of the metabolic syndrome.
    Obunai K; Jani S; Dangas GD
    Med Clin North Am; 2007 Nov; 91(6):1169-84, x. PubMed ID: 17964915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.
    Dekker JM; Girman C; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
    Circulation; 2005 Aug; 112(5):666-73. PubMed ID: 16061755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome: prevalence, CHD risk, and treatment.
    Sarti C; Gallagher J
    J Diabetes Complications; 2006; 20(2):121-32. PubMed ID: 16504841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: Review of current concepts.
    Isezuo SA
    Niger Postgrad Med J; 2006 Sep; 13(3):247-55. PubMed ID: 17278322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.